OTCMKTS:DOCMF Dr. Martens (DOCMF) Stock Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free DOCMF Stock Alerts $0.95 +0.03 (+3.26%) (As of 04/29/2024 ET) Add Compare Share Share Today's Range$0.94▼$0.9550-Day Range$0.83▼$1.2552-Week Range$0.77▼$2.21Volume6,510 shsAverage Volume20,389 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Get Dr. Martens alerts: Email Address Ad True Market InsidersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 About Dr. Martens Stock (OTCMKTS:DOCMF)Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.Read More DOCMF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DOCMF Stock News HeadlinesApril 16, 2024 | marketbeat.comDr. Martens dour US revenue outlook for the year sends stock of iconic bootmaker plungingChunky bootmaker Dr. Martens is warning of a tough year aheadApril 29, 2024 | msn.comDominic Fike Is Paying Musical Tribute to Dr. Martens: Shop His Favorite StylesApril 29, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)April 25, 2024 | msn.comDr. Martens Chief Product Officer on How Balancing Brand Heritage with Innovation Can Reignite DemandApril 21, 2024 | msn.comSuitors from world's leading fashion companies try bootmaker Dr Martens on for sizeApril 19, 2024 | msn.comDr. Martens in crisis:Counterfeit Scandal causes drop in valueApril 19, 2024 | msn.comDr. Martens faces historic low as counterfeits flood marketApril 19, 2024 | yahoo.comDominic Fike Partners With Dr. Martens to Celebrate a New Era of the 1460 Icon BootApril 29, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)April 18, 2024 | msn.com5 Unexpected Insights About Dr. Martens CustomersApril 18, 2024 | msn.comHere’s Why We’re Wearing Dr. Martens To Our Next Music FestivalApril 17, 2024 | msn.comHere's Why We're Wearing Dr. Martens To Our Next Music FestivalApril 17, 2024 | seekingalpha.comDr. Martens: Weak FY2025 Outlook Due To Continued Challenges, A Cautious BuyApril 17, 2024 | msn.comDr Martens CEO Kenny Wilson to step downApril 16, 2024 | investopedia.comDr. Martens Stock Plummets on Downbeat US OutlookApril 16, 2024 | msn.comDr Martens shares plunge as tough outlook sets challenge for new CEOApril 16, 2024 | wsj.comDr. Martens Shares Plunge on Profit Warning, CEO ExitApril 16, 2024 | finance.yahoo.comDr. Martens stock plunges on 2025 warning, CEO departureApril 16, 2024 | cnbc.comDr. Martens shares plunge 30% to all-time low, trading briefly halted on weak outlookApril 14, 2024 | msn.comDr Marten sues Temu over use of trademark on Google searchApril 6, 2024 | yahoo.comThese TikTok-Famous Dr. Martens Mary Jane Shoes Easily Add Some Cool-Girl Edge to Your Feminine Spring Style — And They’re 40% Off TodayApril 3, 2024 | msn.comInvestors urge Dr. Martens to explore potential saleApril 3, 2024 | msn.comDr Martens should carry out major strategic review, investor claimsApril 3, 2024 | msn.comLondon stocks open lower following global downturn; Dr. Martens shinesApril 2, 2024 | msn.comDr Martens boots that are 'so comfy out of the box' reduced by 50%April 2, 2024 | finance.yahoo.comExclusive-Marathon Partners pushes Dr. Martens for strategic review, possible saleApril 2, 2024 | finance.yahoo.comMarathon Partners Calls for Strategic Review Process for Dr. MartensSee More Headlines Receive DOCMF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Cyclical Industry Footwear & Accessories Sub-IndustryN/A Current SymbolOTCMKTS:DOCMF CUSIPN/A CIKN/A Webwww.drmartensplc.com Phone44-12-1415-7047FaxN/AEmployees2,591Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Kenneth Wilson (Age 58)CEO & Director Comp: $961.29kMr. Jon William Mortimore (Age 57)CFO & Director Comp: $625.52kMr. Onyeije Ogueri Nwokorie (Age 54)Chief Brand Officer Comp: $83.32kMr. Geert Peeters (Age 58)Chief Operating Officer Mr. Ronald GarricksChief Information OfficerMs. Meg JohnsonChief Marketing OfficerMs. Emily Clare Reichwald (Age 49)Chief People & Sustainability Officer and Company Secretary Mr. Sean O'NeillChief Digital OfficerMr. Derek ChanPresident of APACMr. Adam M. MeekChief Product OfficerMore ExecutivesKey CompetitorsadidasOTCMKTS:ADDDFAmerican RebelNASDAQ:AREBWASICSOTCMKTS:ASCCFGeoxOTCMKTS:GXSBFPumaOTCMKTS:PUMSYView All Competitors DOCMF Stock Analysis - Frequently Asked Questions Should I buy or sell Dr. Martens stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dr. Martens in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" DOCMF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCMF, but not buy additional shares or sell existing shares. View DOCMF analyst ratings or view top-rated stocks. How have DOCMF shares performed in 2024? Dr. Martens' stock was trading at $1.1460 at the start of the year. Since then, DOCMF shares have decreased by 17.1% and is now trading at $0.9502. View the best growth stocks for 2024 here. How do I buy shares of Dr. Martens? Shares of DOCMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:DOCMF) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe AI stock to buy right nowStockEarningsGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
